DCOY is trading at 5.5% down now at $7.20 as traders take profits following a sharp financing-driven rally. The stock recently spiked after Decoy Therapeutics announced a private placement providing $3.5 million upfront and up to $21 million total to fund clinical trials for respiratory viral illness programs, and is now pulling back from those gains.[4]